Current studies have found that women of color have higher rates of BRCA1 and BRCA2 mutations than previously expected, and breast cancer in women of color

Chronic Myelogenous leukemia (CML) is a type of blood cancer characterized by the proliferation of myeloid cells. Under normal conditions, these cells

June 16, 2026

Leukemia stem cells

June 16, 2026
Current studies have found that women of color have higher rates of BRCA1 and BRCA2 mutations than previously expected, and breast cancer in women of color
This website uses cookies to improve your experience. By using this website you agree to our Data Protection Policy.
Read more